Manulife (Manufacturers Life Insurance)
CCCC icon

Manulife (Manufacturers Life Insurance)’s C4 Therapeutics CCCC Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,021
Closed -$35.2K – 2919
2025
Q1 		$35.2K Buy
22,021
+448
+2% +$1.34K ﹤0.01% 2859
2024
Q4 		$77.7K Sell
21,573
-20,091
-48% -$99.9K ﹤0.01% 2875
2024
Q3 		$237K Buy
41,664
+18,746
+82% +$113K ﹤0.01% 2590
2024
Q2 		$106K Sell
22,918
-49,300
-68% -$294K ﹤0.01% 2808
2024
Q1 		$590K Buy
72,218
+45,889
+174% +$356K ﹤0.01% 2133
2023
Q4 		$149K Buy
+26,329
New +$60K ﹤0.01% 2718
2023
Q3 		– Sell
-65,195
Closed -$179K – 2981
2023
Q2 		$179K Sell
65,195
-16,556
-20% -$53.2K ﹤0.01% 2656
2023
Q1 		$257K Hold
81,751
– – ﹤0.01% 2405
2022
Q4 		$473K Sell
81,751
-36
-0% -$298 ﹤0.01% 2031
2022
Q3 		$702K Sell
81,787
-6,902
-8% -$71.7K ﹤0.01% 1773
2022
Q2 		$655K Buy
88,689
+3,723
+4% +$32.8K ﹤0.01% 1866
2022
Q1 		$2.05M Buy
84,966
+65,224
+330% +$1.58M ﹤0.01% 1494
2021
Q4 		$646 Buy
19,742
+352
+2% +$13.9K ﹤0.01% 2096
2021
Q3 		$866K Buy
19,390
+308
+2% +$13.2K ﹤0.01% 1931
2021
Q2 		$722K Buy
19,082
+12,964
+212% +$464K ﹤0.01% 2182
2021
Q1 		$226K Sell
6,118
-62
-1% -$2.47K ﹤0.01% 2819
2020
Q4 		$205K Buy
+6,180
New +$179K ﹤0.01% 2758

Other funds holding CCCC

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CCCC Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of C4 Therapeutics (CCCC) in Q2 2025, closing a stake of 22,021 shares — an estimated $35.2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CCCC in Q4 2020 and held it in 17 quarters. The position peaked at $2.05M in Q1 2022. 102 funds tracked by Wall St. Rank hold CCCC as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining C4 Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 22,021 C4 Therapeutics shares in Q2 2025, an estimated $35.2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in C4 Therapeutics in Q4 2020 and held it in 17 quarters.
  • Manulife (Manufacturers Life Insurance)'s C4 Therapeutics position peaked at $2.05M in Q1 2022.
  • 102 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.